Literature DB >> 25560185

Characterizing readmission in ulcerative colitis patients undergoing restorative proctocolectomy.

Thomas P Hanzlik1, Sarah E Tevis, Pasithorn A Suwanabol, Evie H Carchman, Bruce A Harms, Charles P Heise, Eugene F Foley, Gregory D Kennedy.   

Abstract

BACKGROUND: Postoperative readmissions increase costs and affect patient quality of life. Ulcerative colitis (UC) patients are at a high risk for hospital readmission following restorative proctocolectomy (RP).
OBJECTIVE: The objective of this study is to characterize UC patients undergoing RP and identify causes and risk factors for readmission.
DESIGN: A retrospective review of a prospectively maintained institutional database was performed. Postoperative readmission rates and reasons for readmission were examined following RP. Univariate and multivariate analyses were performed to evaluate for risk factors associated with readmission.
RESULTS: Of 533 patients who met our inclusion criteria, 18.2 % (n = 97) were readmitted within 30 days while 22.7 % (n = 121) were readmitted within 90 days of stage I of RP. Younger patient age (OR 1.825, 95 % CI 1.139-2.957), laparoscopic approach (OR 1.943, 95 % CI 1.217-3.104), and increased length of initial stay (OR 1.155, 95 % CI 1.090-1.225) were all associated with 30-day readmission. The most common reason for readmission was dehydration/ileus/partial bowel obstruction, with 10 % of patients readmitted for this reason within 30 days.
CONCLUSIONS: Patients undergoing restorative proctocolectomy are at high risk for readmission, particularly following the first stage of the operation. Novel treatment pathways to prevent ileus and dehydration as an outpatient may decrease the rates of readmission following RP.

Entities:  

Mesh:

Year:  2015        PMID: 25560185      PMCID: PMC4565166          DOI: 10.1007/s11605-014-2734-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

2.  One-stage restorative proctocolectomy without temporary ileostomy for ulcerative colitis: a note of caution.

Authors:  M E Williamson; W G Lewis; P M Sagar; P J Holdsworth; D Johnston
Journal:  Dis Colon Rectum       Date:  1997-09       Impact factor: 4.585

Review 3.  Omission of temporary diversion in restorative proctocolectomy--is it safe?

Authors:  J J Tjandra; V W Fazio; J W Milsom; I C Lavery; J R Oakley; J M Fabre
Journal:  Dis Colon Rectum       Date:  1993-11       Impact factor: 4.585

4.  Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis.

Authors:  J Gu; L Stocchi; F Remzi; R P Kiran
Journal:  Colorectal Dis       Date:  2013-09       Impact factor: 3.788

5.  Hospital readmissions as a measure of quality of health care: advantages and limitations.

Authors:  J Benbassat; M Taragin
Journal:  Arch Intern Med       Date:  2000-04-24

6.  Dehydration is the most common indication for readmission after diverting ileostomy creation.

Authors:  Evangelos Messaris; Rishabh Sehgal; Susan Deiling; Walter A Koltun; David Stewart; Kevin McKenna; Lisa S Poritz
Journal:  Dis Colon Rectum       Date:  2012-02       Impact factor: 4.585

7.  Key factors associated with postoperative complications in patients undergoing colorectal surgery.

Authors:  E Manilich; J D Vogel; R P Kiran; J M Church; Dilara Seyidova-Khoshknabi; F H Remzi
Journal:  Dis Colon Rectum       Date:  2013-01       Impact factor: 4.585

8.  Multivariable analysis of factors associated with hospital readmission after intestinal surgery.

Authors:  Yehuda Kariv; Wei Wang; Anthony J Senagore; Jeffrey P Hammel; Victor W Fazio; Conor P Delaney
Journal:  Am J Surg       Date:  2006-03       Impact factor: 2.565

9.  Ileostomy pathway virtually eliminates readmissions for dehydration in new ostomates.

Authors:  Deborah Nagle; Therese Pare; Emily Keenan; Kristin Marcet; Steven Tizio; Vitaliy Poylin
Journal:  Dis Colon Rectum       Date:  2012-12       Impact factor: 4.585

10.  Factors predicting hospital length-of-stay and readmission after colorectal resection: a population-based study of elective and emergency admissions.

Authors:  Maria Kelly; Linda Sharp; Fiona Dwane; Tracy Kelleher; Harry Comber
Journal:  BMC Health Serv Res       Date:  2012-03-26       Impact factor: 2.655

View more
  5 in total

Review 1.  Postoperative Complications: Looking Forward to a Safer Future.

Authors:  Sarah E Tevis; Gregory D Kennedy
Journal:  Clin Colon Rectal Surg       Date:  2016-09

2.  Thirty-Day Hospital Readmission After Restorative Proctocolectomy and Ileal Pouch Anal Anastomosis for Chronic Ulcerative Colitis at a High-Volume Center.

Authors:  Nicholas P McKenna; Kellie L Mathis; Mohammad Khasawneh; Omair Shariq; Eric J Dozois; David W Larson; Amy L Lightner
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

3.  Rate of Risk Factors for and Interventions to Reduce Hospital Readmission in Patients With Inflammatory Bowel Diseases.

Authors:  Nghia H Nguyen; Jejo Koola; Parambir S Dulai; Larry J Prokop; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-27       Impact factor: 11.382

4.  Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.

Authors:  Priti Poojary; Aparna Saha; Kinsuk Chauhan; Priya Simoes; Bruce E Sands; Judy Cho; Thomas Ullman; Girish Nadkarni; Ryan Ungaro
Journal:  Inflamm Bowel Dis       Date:  2017-03       Impact factor: 5.325

5.  Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.

Authors:  Matthew D Egberg; Michael Phillips; Joseph A Galanko; Michael Kappelman
Journal:  Inflamm Bowel Dis       Date:  2021-03-15       Impact factor: 5.325

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.